europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Newsletter
    • Library
Become a member
✕

Factsheet – Vision for Europe: Innovation

11/10/2022
FACTSHEET

Innovation

Europe must lead the world in scientific and industrial innovation.

Science
Create an environment which fosters scientific progress which will result in tangible social benefits.

Regulation
Establish a future-proof EU regulatory framework which removes barriers to innovation and allows tomorrow’s technologies to be developed and launched in Europe first.

Infrastructure
Strengthen the links between scientific knowledge and industrial capabilities by encouraging partnerships that can support infrastructures for biotechnology to ensure efficient, impactful, and rapid progress.

Competitiveness
Provide companies with the appropriate tools, incentives, and frameworks to ensure they can compete globally.

Growth
Harness the innovation created by the healthcare biotechnology sector to unleash its economic potential, creating high-skill jobs and value for citizens.

Accessibility
Address regulatory barriers and other factors to improve accessibility of therapeutic innovations for the benefits of patients.

Factsheet - Vision for Europe: Innovation


Download
Europabio-Factsheets-Page1_InnovationDownload
Share
Alexandra Simionca
Alexandra Simionca

Related posts

13/12/2022

EuropaBio Principles for Genetic Testing and Testing for Genetically-Driven Risk Factor


Read more
08/12/2022

‘Rare Disease Moonshot’ – Scaling-up public-private partnerships to accelerate research into world’s rarest diseases


Read more
02/12/2022

EuropaBio’s 2022 Patient BioForum addresses the challenges of patients with unmet medical needs and calls for multi-stakeholder approach


Read more
28/11/2022

Enabling Patient Access to Transformational Therapeutic Innovations: Modernising the EU’s Cross-Border Healthcare Framework


Read more

Important links

  • Unlocking the Potential of Biotechnology Innovation for Patients
  • Vision, clarity and enabling – the drivers for Europe’s biomanufacturing future

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies